Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
NMR in Biomedicine|April 9, 1999
Quantifying 1H decoupled in vivo 31P brain spectraJ J Potwarka, D J Drost, P C WilliamsonBiological Psychiatry|April 3, 1999
A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controlsJ J Potwarka, D J Drost, P C Williamson, et al.NMR in Biomedicine|July 28, 1999
Factors affecting the quantification of short echo in-vivo 1H MR spectra: prior knowledge, peak elimination, and filteringR Bartha, D J Drost, P C WilliamsonMagnetic Resonance in Medicine|August 5, 2000
Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 TeslaR Bartha, D J Drost, R S Menon, et al.Magnetic Resonance in Medicine|October 12, 2000
Spectroscopic lineshape correction by QUECC: combined QUALITY deconvolution and eddy current correctionR Bartha, D J Drost, R S Menon, et al.Magnetic Resonance in Medicine|July 1, 1995
The use of a priori knowledge to quantify short echo in vivo 1H MR spectraJ A Stanley, D J Drost, P C Williamson, et al.Schizophrenia Bulletin|January 1, 1996
An in vivo proton magnetic resonance spectroscopy study of schizophrenia patientsJ A Stanley, P C Williamson, D J Drost, et al.Archives of General Psychiatry|May 1, 1995
An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopyJ A Stanley, P C Williamson, D J Drost, et al.Schizophrenia Research|October 1, 1994
Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy studyJ A Stanley, P C Williamson, D J Drost, et al.Archives of General Psychiatry|October 24, 1997
Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopyR Bartha, P C Williamson, D J Drost, et al.Pageof 7